RE:Open labelThey can tell us anything they want at any time. Common practice in the industry, however, does not lead to a super open discussion of the progress in the trial as we have seen with TH. But they did finally get around to telling us that patient #2 was on the drug for at least 4 cycles (probably more than that) and that is a sizablehint that they have seen agood reaction to TH-1902 with at this one patient. They likely could have toldus that months earlier but they curate this info for maximum impact, particularly when a company is in a fundraising mode as TH likely is.
Biobob wrote: Anyone knows if they can update on Th1902 efficacity signs if they occur in 1a with their open label status. Or is it only in 1b that it's the case.